Intermediate-High Risk Pulmonary Embolism: The Use of Riociguat and Inferior Vena Cava Filter in a Situation of Recurrent Embolism following Insufficient Anticoagulation and Fibrinolytic Therapy
Case Reports in Anesthesiology · 15.10.2020 · 2020 · 1-5
DOI: 10.1155/2020/4219616 ↗Kurz gefasst
Fallbericht in der Zeitschrift Case Reports in Anesthesiology, erschienen am 15.10.2020. Verfasst von Anh Khoi Vo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Haukeland University Hospital, Bergen, Norway. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Pulmonary embolism (PE) is associated with serious morbidity and mortality. In this case report, we describe a hemodynamically stable patient with submassive PE and a large thrombus in the inferior vena cava (IVC) protruding into the right atrium (RA), complicated by severe respiratory failure, elevated troponin T (TnT), and right ventricular (RV) dysfunction. The patient was stratified as intermediate-high risk of early death. Important issues regarding the initial choice of anticoagulation, rescue thrombolytic therapy, and benefits of adding riociguat to stimulate the nitric oxide-soluble guanylate cyclase-cyclic guanosine monophosphate (NO-sGC-cGMP) pathway to improve the RV function are discussed. Finally, we address appropriate timing and the use of IVC filter in a situation of recurrent PE following anticoagulation and fibrinolytic therapy.
Autor:innen und Institutionen
- Department of Medicine, Haukeland University Hospital, Bergen, Norway.
- Department of Clinical Science, University of Bergen, Bergen, Norway.
- Department of Heart Disease, Haukeland University Hospital, Bergen, Norway.
- Department of Radiology, Haukeland University Hospital, Bergen, Norway.
- Department of Anaesthesiology and Intensive Care, Haukeland University Hospital, Bergen, Norway.
- VID Specialized University, Faculty of Health, Bergen, Norway.
ORCID-Profile: Håkon Reikvam, Øystein Wendelbo
Zitieren
APA
Vo, A. K., Reikvam, H., Midtbø, H., Wirsching, J. L., Bruserud, Ø., & Wendelbo, Ø. (2020). Intermediate-High Risk Pulmonary Embolism: The Use of Riociguat and Inferior Vena Cava Filter in a Situation of Recurrent Embolism following Insufficient Anticoagulation and Fibrinolytic Therapy. Case Reports in Anesthesiology, 2020, 1-5. https://doi.org/10.1155/2020/4219616
Vancouver
Vo AK, Reikvam H, Midtbø H, Wirsching JL, Bruserud Ø, Wendelbo Ø. Intermediate-High Risk Pulmonary Embolism: The Use of Riociguat and Inferior Vena Cava Filter in a Situation of Recurrent Embolism following Insufficient Anticoagulation and Fibrinolytic Therapy. Case Reports in Anesthesiology. 2020;2020:1-5. doi:10.1155/2020/4219616
BibTeX
@article{Vo2020,
author = {Vo, Anh Khoi and Reikvam, Håkon and Midtbø, Helga and Wirsching, Jan Ludvig and Bruserud, Øyvind and Wendelbo, Øystein},
title = {Intermediate-High Risk Pulmonary Embolism: The Use of Riociguat and Inferior Vena Cava Filter in a Situation of Recurrent Embolism following Insufficient Anticoagulation and Fibrinolytic Therapy},
journal = {Case Reports in Anesthesiology},
year = {2020},
volume = {2020},
pages = {1--5},
doi = {10.1155/2020/4219616}
}
EUVIMED